Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies Meeting Abstract
| Authors: | Modak, S.; Pandit Taskar, N.; Kushner, B.; Zanzonico, P.; Humm, J.; Donzelli, M.; Lewis, J.; Lyashchenko, S.; Chu, B.; Larson, S.; Cheung, N. K.; Kramer, K. |
| Abstract Title: | Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies |
| Meeting Title: | 54th Congress of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 69 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2022-11-01 |
| Start Page: | S104 |
| End Page: | S105 |
| Language: | English |
| ACCESSION: | WOS:000859203900213 |
| PROVIDER: | wos |
| DOI: | 10.1002/pbc.29952 |
| Notes: | Meeting Abstract: O213 / #732 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
